儿童获得性甲状腺功能减退症诊断前生长异常的早期识别
该回顾性病例对照研究分析了109例芬兰儿童获得性甲状腺功能减退症(JHT)患者诊断前5年的554次身高体重测量,并与按性别年龄匹配的健康对照比较。发现JHT患者诊断时更重更矮,但诊断前5年反而更重更高,生长异常模式在诊断前数年已逐渐显现。系统生长监测可早期识别异常生长,有助于及时诊断JHT。
要点
- JHT诊断前数年已出现生长异常,表现为体重增加伴线性生长变化。
- 诊断时JHT患者BMI较对照高0.65 SDS,身高较靶身高低0.34 SDS。
- 联合多个生长参数筛查可较好识别JHT(AUC 0.83)。
核心结论
- JHT患者的异常生长模式在诊断前数年即已演变,系统生长监测有助于早期发现并及时诊断。
研究设计与样本
- 回顾性病例对照研究,纳入109例来自3家芬兰大学医院的JHT患者(年龄1.2–15.6岁,生于1983–2010年),获取诊断前5年的554次身高体重测量。
- 每例患者按性别和年龄与100名健康对照(生于1983–2008年)配对,采用混合线性模型评估纵向生长模式,并用ROC分析评估生长监测参数。
主要发现
- 诊断时JHT患者较健康对照更重(平均调整BMISDS差异0.65,95%CI 0.46–0.84)且更矮(平均调整THDEVSDS差异-0.34,95%CI -0.57至-0.10)。
- 诊断前5年JHT患者较对照更重(平均BMISDS差异0.33,95%CI 0.12–0.54)且更高(平均THDEVSDS差异0.29,95%CI 0.06–0.52)。
- 联合多个生长参数筛查可较好识别JHT(曲线下面积0.83,95%CI 0.78–0.89)。
关键数值与推荐
- 诊断时平均调整BMISDS差异0.65(95%CI 0.46–0.84),平均调整THDEVSDS差异-0.34(95%CI -0.57至-0.10)。
- 诊断前5年平均BMISDS差异0.33(95%CI 0.12–0.54),平均THDEVSDS差异0.29(95%CI 0.06–0.52)。
- 多参数联合筛查的AUC为0.83(95%CI 0.78–0.89)。
临床怎么用
- 在儿童系统生长监测中关注体重增加伴身高增长偏离靶身高的模式,警惕JHT可能。
- 对生长异常儿童可联合多个生长参数评估,提高JHT早期识别准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Development of the typical growth phenotype in juvenile acquired hypothyroidism (JHT), the faltering linear growth with increasing weight, has not been thoroughly characterized. OBJECTIVE: To describe longitudinal growth pattern in children developing JHT and investigate how their growth differs from the general population in systematic growth monitoring. DESIGN: Retrospective case-control study. SETTING: JHT cases from 3 Finnish University Hospitals and healthy matched controls from primary health care. PATIENTS: A total of 109 JHT patients aged 1.2 to 15.6 years (born 1983-2010) with 554 height and weight measurements obtained for 5 years preceding JHT diagnosis. Each patient was paired with 100 healthy controls (born 1983-2008) by sex and age. Longitudinal growth pattern was evaluated in mixed linear models. Growth monitoring parameters were evaluated using receiver operating characteristics analysis. RESULTS: At diagnosis, JHT patients were heavier (mean adjusted body mass index-for-age [BMISDS] difference, 0.65 [95% CI, 0.46-0.84]) and shorter (mean adjusted height-for-age deviation from the target height [THDEVSDS] difference, -0.34 [95% CI, -0.57 to -0.10]) than healthy controls. However, 5 years before diagnosis, patients were heavier (mean BMISDS difference, 0.33 [95% CI, 0.12-0.54]) and taller (mean THDEVSDS difference, 0.29 [95% CI, 0.06-0.52]) than controls. JHT could be detected with good accuracy when several growth parameters were used simultaneously in screening (area under the curve, 0.83 [95% CI, 0.78-0.89]). CONCLUSIONS: Abnormal growth pattern of patients with JHT evolves years before diagnosis. Systematic growth monitoring would detect abnormal growth at an early phase of JHT and facilitate timely diagnosis of JHT.
引用
- Saari A, Pokka J, Mäkitie O, et al. Early Detection of Abnormal Growth Associated with Juvenile Acquired Hypothyroidism. J Clin Endocrinol Metab. 2021. PMID: 33245341. doi:10.1210/clinem/dgaa869
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。